Laurie Gutmann

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Nosocomial Acquisition of Multiresistant Acinetobacter baumannii: Risk Factors and Prognosis

Olivier Lortholary, J.-Y. Fagon, Annie Buu Hoï et al. · Clinical Infectious Diseases · 1995 · 250 citations

Life Sciences, Infectious Diseases, Microbiology +17

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban et al. · The Lancet Neurology · 2019 · 223 citations · Full text

Medicine, Endocrinology, Surgery +5

Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes

Andrea Cortese, Yi Zhu, Adriana Rebelo et al. · Nature Genetics · 2020 · 177 citations · Full text

Medicine, Genetics, Molecular Genetics +11

Admission neutrophil–lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy

Steven Brooks, Chauncey Spears, Christopher L. Cummings et al. · Journal of NeuroInterventional Surgery · 2013 · 157 citations · Full text

Life Sciences, Clinical Sciences, Immunology +16